News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects Todd Neale August 21, 2019
News Daily News Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts Michael O'Riordan August 09, 2019
News Daily News Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk Marcus A. Banks July 24, 2019
News Industry News Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure July 23, 2019
News Daily News CV Risk Factors in Youth May Prove Indelible for Later CAD Marcus A. Banks July 17, 2019
News Daily News ‘These Are Good Organs’: Drug Overdose Deaths Boost Transplants, With Few Downsides Todd Neale June 10, 2019
News Conference News ESC Heart Failure 2019 Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG Shelley Wood May 28, 2019
News Conference News ESC Heart Failure 2019 Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis Shelley Wood May 26, 2019
News Conference News SCAI 2019 National Cardiogenic Shock Initiative Shows Potential to Increase Survival Yael L. Maxwell May 23, 2019
News Conference News EuroPCR 2019 MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT Shelley Wood May 21, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Daily News Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor Michael O'Riordan April 12, 2019
News Daily News There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends Todd Neale April 10, 2019
News Daily News Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks Michael O'Riordan April 10, 2019
Presentation ACC 2019 Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial Presenter: Adam D. DeVore March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Daily News Sex-Based Differences for Heart Failure Risk Need More Attention, Research Yael L. Maxwell February 28, 2019